Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of cancer
3.2.1.2 Growing advancement in diagnostic technologies
3.2.1.3 Increased investments in cancer research
3.2.1.4 Growing awareness and screening programs
3.2.2 Industry pitfalls & challenges
3.2.2.1 High costs of advanced diagnostics technologies
3.2.2.2 Stringent regulations and lengthy approval processes
3.3 Growth potential analysis
3.4 Future market trends
3.5 Technology landscape
3.6 Pricing analysis
3.7 Regulatory landscape
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product & Service, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Products
5.2.1 Instruments
5.2.2 Kits & consumables
5.3 Services
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Next-generation sequencing (NGS)
6.3 Polymerase chain reaction (PCR)
6.4 DNA microarrays
6.5 Multiplexing
6.6 Other technologies
Chapter 7 Market Estimates and Forecast, By Cancer Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Breast cancer
7.3 Lung cancer
7.4 Colorectal cancer
7.5 Prostate cancer
7.6 Cervical cancer
7.7 Liver cancer
7.8 Other cancer types
Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Screening and early detection
8.3 Prognostics and monitoring
8.4 Therapy selection
8.5 Recurrence monitoring
8.6 Other applications
Chapter 9 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospitals & clinics
9.3 Diagnostic laboratories
9.4 Academic & research institutions
9.5 Other end users
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Netherlands
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
Chapter 11 Company Profiles
11.1 Agilent
11.2 Almac
11.3 Bio-Rad Laboratories
11.4 Exact Sciences
11.5 F. Hoffmann-La Roche
11.6 GenScript
11.7 Guardant Health
11.8 Illumina
11.9 Karkinos Healthcare
11.10 Qiagen
11.11 Koninklijke Philips
11.12 Thermo Fisher Scientific
